Renal Cell Cancer Clinical Trials

A listing of Renal Cell Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Muscle Shoals Alabama 35661

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Arizona

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Scottsdale Arizona 85258

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

California

Duarte California 91010

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

La Jolla California 92037

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

La Jolla California 92093

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Orange California 92868

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Panorama City California 91402

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

San Francisco California 94143

A clinical research study of CPI-444 and CPI-444 + atezolizumab

San Francisco California 94143

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Santa Monica California 90403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Santa Rosa California 95403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Colorado

Aurora Colorado 80045

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Aurora Colorado 80045

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Aurora Colorado 080045

Patients are needed to participate in a clinical research study of IMMU-132

Connecticut

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of IMMU-132

Delaware

Newark Delaware 19713

Patients are needed to participate in a clinical research study of IMMU-132

District of Columbia

Washington District of Columbia 20007

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Florida

Orlando Florida 32806

Patients are needed to participate in a clinical research study of IMMU-132

Tampa Florida 33612

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Tampa Florida 33612

Patients are needed to participate in a clinical research study of IMMU-132

Weston Florida 33331

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Georgia

Athens Georgia 30607

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Atlanta Georgia 30322

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Newnan Georgia 30265

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Hawaii

Honolulu Hawaii 96813

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Illinois

Chicago Illinois 60637

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Chicago Illinois 60611

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Park Ridge Illinois 60068

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Zion Illinois 60099

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Indiana

Goshen Indiana 46526

Patients are needed to participate in a clinical research study of IMMU-132

Indianapolis Indiana 46202

A clinical research study of CPI-444 and CPI-444 + atezolizumab

New Albany Indiana 47150

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Louisiana

Metairie Louisiana 70006

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Metairie Louisiana 70006

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Metairie Louisiana 70006

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Maine

Brunswick Maine 04011

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Kennebunk Maine 04043

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Scarborough Maine 04074

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Maryland

Baltimore Maryland 21287

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Bethesda Maryland 20892

Patients are needed to participate in a clinical research study evaluating hetIL-15 for the treatment of Skin Melanoma, Renal Cell Cancer, Non-Small Cell Lung Cancer or Head and Neck Squamous Cell Carcinoma

Massachusetts

Boston Massachusetts 02215

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced

Boston Massachusetts 02215

A clinical research study of Avelumab (MSB0010718C) and Axitinib (AG-013736) for the treatment of Renal Cell Cancer, Advanced